Furthermore, the comparison of the patients with AIE associated with anti-LG1 and anti-CASPR2 antibodies revealed that none of those with anti-CASPR2 antibodies had dystonia or other movement disorders, while it was significantly common in patients with AIE associated with anti-LG1 antibodies. This evidence concerns the gene CNTNAP2 and Dystonia.